Related Experiment Video

Updated: May 12, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

[Catheter ablation in atrial fibrillation: a valid therapeutic option also for older patients?]

Antonio Sorgente, Riccardo Cappato

    Giornale Italiano Di Cardiologia (2006)
    |April 25, 2013
    PubMed

    Insights

    Atrial fibrillation (AF) is common in older adults. Catheter ablation offers a potentially curative treatment option for elderly patients with AF, avoiding drug side effects.

    Area of Science:

    • Cardiology
    • Geriatrics
    • Electrophysiology

    Background:

    • Atrial fibrillation (AF) is the most prevalent cardiac arrhythmia, increasing with age and linked to significant morbidity and mortality.
    • Pharmacological treatment of AF in the elderly presents challenges due to age-related physiological changes and drug-related side effects.
    • Catheter ablation is emerging as a therapeutic alternative for AF in older populations.

    Purpose of the Study:

    • To review the current evidence on the safety and efficacy of catheter ablation for atrial fibrillation in geriatric patients.
    • To provide a balanced perspective on catheter ablation for AF in the elderly, considering both electrophysiologists' enthusiasm and geriatricians' concerns.

    Main Methods:

    • Review of existing literature on catheter ablation for atrial fibrillation in patients aged 65 and older.
    • Analysis of studies focusing on safety outcomes, efficacy rates, and specific challenges in the geriatric population.

    Main Results:

    • Catheter ablation demonstrates promising safety and efficacy in selected elderly patients with atrial fibrillation.
    • Age-related factors require careful consideration for patient selection and procedural management.
    • The review aims to reconcile the benefits of ablation with potential geriatric-specific risks.

    Conclusions:

    • Catheter ablation is a viable therapeutic option for managing atrial fibrillation in the elderly.
    • Further research is needed to optimize patient selection and procedural techniques for this demographic.
    • Balancing the benefits of ablation against the complexities of geriatric care is crucial for successful outcomes.

    More Related Videos

    Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology10:46

    Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology

    Published on: May 26, 2015

    Robotic Ablation of Atrial Fibrillation11:21

    Robotic Ablation of Atrial Fibrillation

    Published on: May 29, 2015

    Related Concept Videos

    Dysrhythmias VI: Management of Dysrhythmias01:25

    Dysrhythmias VI: Management of Dysrhythmias

    Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
    Heart Failure VI: Adjunct Therapies01:22

    Heart Failure VI: Adjunct Therapies

    Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
    ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

    ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

    Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
    Cardiomyopathy V: Interprofessional Care01:29

    Cardiomyopathy V: Interprofessional Care

    Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
    Heart Failure V: Medical Management01:30

    Heart Failure V: Medical Management

    Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
    Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

    Cardiomyopathy III: Hypertrophic Cardiomyopathy

    Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...